Superworth

QT Imaging price to sales ratio QTI

Market value divided by revenue over the last twelve months, since 2025.

Today, Oct 23, 2026
1.2×
Peer median
1.4×

QT Imaging's price to sales ratio is 1.2× as of Oct 23, 2026.

The median for 10 healthcare stocks of a similar size is 1.4×.

Price to sales ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far1.2×1.2×7.2×
20256.2×3.2×24.0×

Against its peers

Companies in Healthcare nearest QT Imaging's size, closest first, today.

CompanyPrice to sales ratio
QTIQT Imaging1.2×
NEPHNephros1.9×
ATNMActinium Pharmaceuticalsn/m
APTAlpha Pro Tech0.9×
SPROSpero Therapeutics1.4×
LFVNLifevantage0.4×
ICCCImmucell3.0×
KEQUKewaunee Scientific0.3×
PDEXPro DEX2.6×
PLXProtalix BioTherapeutics2.5×
NATRNatures Sunshine Products0.4×
Peer median1.4×

Where QT Imaging ranks

What the price to sales ratio tells you

Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.

Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.

More on QT Imaging

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.